COVID-19 in Relation to Chronic Antihistamine Prescription.

ABSTRACT: No hospitalizations or deaths occurred in residents with the COVID-19 infection, treated with antihistamines and azithromycin, of two external nursing homes during the first wave. We assessed whether patients receiving chronic antihistamines in our institution showed better clinical evolution. COVID-19 admissions and related deaths in the public Hospital of Terrassa (n = 1461) during the pandemic period (11 March 2020-5 May 2023) and cases (n = 32,888) during the period of full suspicion diagnosis (1 June 2020-23 March 2022) were referred to as the number of chronic treatments (nT) including or not including antihistamines (AntiHm or NOAntiHm), and their vaccination status before the first infection (VAC or NoVAC) in our assigned population (n = 140,681 at March 2020)

SUBMITTER: Puigdellivol-Sanchez A 

PROVIDER: S-EPMC11676390 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature